Ban of Butylphenyl Methylpropional Postponed in the UK
Due to its classification as toxic to reproduction (Repr.1B - CMR 1B), Butylphenyl Methylpropional is now prohibited in cosmetic products in the European Union. Currently, this ingredient can still be used (subject to restrictons) in cosmetics marketed in Great Britain. However, a ban on Butylphenyl Methylpropional is expected in the near future in GB.
Marta Pinto

Marta Pinto

Regulatory Affairs Associate

BUTYLPHENYL METHYLPROPIONAL

Butylphenyl Methylpropional, commonly known as Lilial (main trade name) or p-BMHCA, is an aromatic aldehyde, a synthetic fragrance ingredient that has been used for years in different types of cosmetics and personal care products. Butylphenyl Methylpropional is also used in several non-cosmetic products, like household cleaners and detergents.

Opinions issued by the European Commission’s Scientific Committee on Consumer Safety (SCCS) have expressed concern about this ingredient (risk of skin sensitization, aggregate exposure). Butylphenyl Methylpropional as a net compound revealed to be irritating to the skin and eyes of rabbits. Moreover, this ingredient poses a risk of inducing skin sensitization in humans. (see previous post)

BUTYLPHENYL METHYLPROPIONAL PROHIBITED IN COSMETIC PRODUCTS IN THE EU

In May 2020, the European Commission published the Commission Delegated Regulation No. 2020/1182, regarding the classification, labelling and packaging of substances and mixtures (amendment to CLP Regulation (EC) No. 1272/2008). In accordance with this amendment to the CLP Regulation, Butylphenyl Methylpropional is now classified as Repr. 1B (toxic to reproduction – CMR 1B), applying from 1st of March 2022. (see previous post)

According to the European Cosmetic Regulation ((EC) No 1223/2009), the use of substances classified as CMR (carcinogenic, mutagenic or toxic to reproduction, under the CLP Regulation) is banned.

As of March 1, 2022, Butylphenyl Methylpropional can no longer be used in cosmetic products marketed in the European Union (EU). This ingredient is currently included in list of the substances prohibited in cosmetic products (Annex II, entry 1666) of the European Cosmetics Regulation (No 1223/2009).

This applies to all cosmetic products, both new cosmetics and products already placed on the market. Since the beggining of this month, all products containing Butylphenyl Methylpropional must be off shelves!

BUTYLPHENYL METHYLPROPIONAL IN THE UK

Cosmetic products placed on the Great Britain (GB – England, Wales and Scotland) market must comply with Schedule 34 of the Product Safety and Metrology Statutory Instrument (UK Cosmetics Regulation). (see previous post)

On 14th February, the Cosmetic, Toiletry & Perfumery Association (CTPA), which represents all types of companies involved in making, supplying and selling cosmetic and personal care products in the UK, published a public statement regarding the legal status of Butylphenyl Methylpropional in GB.

CTPA clarifies that “the legal status of BMHCA/Lilial in GB is different from that in the EU/NI, as different legislations are applicable in the two markets. CTPA expects a ban on BMHCA/Lilial to come into force in GB in the near future“.

At the moment, Butylphenyl Methylpropional is a restricted fragrance allergen (included in Annex III) and can still be used in cosmetic products marketed in GB. A ban was not published yet, but it is expected in the future.

If you wish to get more information regarding this or other subjects, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. 
  2. Commission Delegated Regulation (EU) No. 2020/1182 of 19 May 2020 amending, for the purposes of its adaptation to technical and scientific progress, Part 3 of Annex VI to Regulation (EC) No. 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures.
  3. The Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019, Schedule 34 – Amendment of Regulation (EC) No 1223/2009 and related amendments. 
  4. CTPA Public Statement on the Legal Status of BMHCA/Lilial in GB. Available from: https://www.ctpa.org.uk/news/ctpa-public-statement-on-the-legal-status-of-bmhcalilial-in-gb-5852

further
reading

drug_device_combination_1
medical devices

Regulatory Framework of Drug-Device Combination

The advances in technology continue to merge different types of products and the historical lines of separation between medical devices and medicinal products are getting thinner. Products combining medicinal products and medical devices are regulated either by Regulation (EU) 2017/745 (MDR) or by Directive 2001/83/EC.

Read More »
cosmetic products

SCCS Preliminary Opinion on Alpha-Arbutin and Beta-Arbutin

Alpha-arbutin and Beta-arbutin are used in cosmetic with antioxidant, bleaching and skin conditioning functions. Following concerns raised during discussion within the Working Group on Cosmetic Products and consequent call for data on these ingredients, the SCCS assessed the safety of Alpha-arbutin and Beta-arbutin in cosmetic products.

Read More »
cosmetic products

Request for SCCS Scientific Opinion on Citral

The European Commission requested the SCCS to assess whether the derived safe use levels for Citral by the application of the QRA2 based on the induction of skin sensitization is adequate to protect consumers. A period of 9 months was set for issuing the scientific opinion.

Read More »
cosmetic products

SCCS Scientific Advice on the Safety of Triclocarban and Triclosan

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

Read More »
cosmetic products

Cosmetic Regulation in the Andean Community

In the Andean Community (Bolivia, Colombia, Ecuador and Peru), cosmetic products are mainly regulated by Decision 833. All cosmetic products made available in these countries must undergo a Mandatory Sanitary Notification (NSO) and need to be manufactured according to Good Manufacturing Practices (GMP).

Read More »
cosmetic products

Cosmetic Product Labelling in the European Union

The Regulation (EC) No 1223/2009 lays down the mandatory information that needs to be included in the packaging and container of a cosmetic products. In addition to this information, most cosmetic products include certain claims, which must be supported and properly substantiated.

Read More »
cosmetic products

Environmental Claims in the UK

Green claims are a trend among consumer goods and services. We often see claims like ‘clean beauty’, ‘environmental friendly’ and so many others. But how can companies ensure that these claims are not misleading? The UK’s Competition and Markets Authority (CMA) has published its Green Claims Code, in order to help companies comply with legal obligations when making environmental claims.

Read More »
cosmetic products

Parabens in Cosmetic Products

Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

Read More »
cosmetic products

The Product Information File (PIF)

A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.

Read More »